Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing

Journal of Acquired Immune Deficiency Syndromes

Volumn 44, Issue 3, 2007, Pages 247-253

  Knuchel, Marlyse C ^a   Jullu, Boniphace ^b   Shah, Cyril ^a   Tomasik, Zuzana ^a   Stoeckle, Marcel P ^b,c   Speck, Roberto F ^d   Nadal, David ^e   Mshinda, Hassan ^b   Böni, Jürg ^a   Tanner, Marcel ^c   Schüpbach, Jörg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Dried blood spot; HIV 1 p24 antigen; Pediatric HIV 1 diagnosis; Plasma HIV 1 RNA; Real time DBS DNA polymerase chain reaction; Resource poor settings

Indexed keywords

ANTIGEN P24; DNA; HYDROGEN PEROXIDE; PEROXIDASE; RNA;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TANZANIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TANZANIA;

EID: 33847297009     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31802c3e67     Document Type: Article

References (39)

1. Behets F, Kashamuka M, Pappaioanou M, et al. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol. 1992;30:1179-1182.
2. Sherman GG, Stevens G, Jones SA, et al. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005;38:615-617.
3. Stevens R, Pass K, Fuller S, et al. Blood spot screening and confirmatory tests for syphilis antibody. J Clin Microbiol. 1992;30:2353-2358.
4. Schupbach J. Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. Int Arch Allergy Immunol. 2003;132:196-209.
5. Schupbach J. Measurement of HIV-1 p24 antigen by signal-amplification- boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev. 2002;4:83-92.
6. Schupbach J, Boni J. Sensitivity of heat-denatured p24 antigen in the diagnosis of pediatric HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:399-400.
7. Schupbach J, Boni J, Bisset LR, et al. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;33:292-299.
8. Schüpbach J, Tomasik Z, Knuchel MC, et al. Optimized virus disruption improves detection of HIV-1 p24 and uncovers p24 in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol. 2006;78:1003-1010.
9. Boni J, Schupbach J. Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Mol Cell Probes. 1993;7:361-371.
10. Schupbach J, Flepp M, Pontelli D, et al. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS. 1996;10:1085-1090.
11. Respess RA, Cachafeiro A, Withum D, et al. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol. 2005;43:506-508.
12. Mascolini M. Transfer of HIV diagnostic and monitoring technologies into resource-poor settings. Available at: http://www.hivforum.org/publications/ TechTransFinal.pdf. 2002. Last accessed November 20, 2006.
13. Sterling TR, Hoover DR, Astemborski J, et al. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. J Infect Dis. 2002;186:1181-1185.
14. Nadal D, Boni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis. 1999;180:1089-1095.
15. Sherman GG, Stevens G, Stevens WS. Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection. Pediatr Infect Dis J. 2004;23:173-176.
16. Brinkhof M, Steiner F, Boni J, et al. Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: better prediction of the CD4 T cell changes between consecutive visits. J Acquir Immune Defic Syndr. 2006;41:557-562.
17. Knuchel MC, Tomasik Z, Speck RF, et al. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings. J Clin Virol. 2006;36:64-67.
18. + loss. J Acquir Immune Defic Syndr. 2005;40:250-256.
19. Bisset LR, Bosbach S, Tomasik Z, et al. Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA isolation. J Virol Methods. 2001;91:149-155.
20. Boni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr. 1999;22:174-179.
21. Arroyo MA, Hoelscher M, Sanders-Buell E, et al. HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. AIDS Res Hum Retroviruses. 2004;20:895-901.
22. Kiwelu IE, Renjifo B, Chaplin B, et al. HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania. AIDS Res Hum Retroviruses. 2003;19:57-64.
23. Renjufi B, Gilbert P, Chaplin B, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS. 2004;18:1629-1636.
24. Koulinska IN, Msamanga G, Mwakagile D, et al. Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. AIDS Res Hum Retroviruses. 2002;18:947-956.
25. Li CC, Seidel KD, Coombs RW, et al. Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J Clin Microbiol. 2005;43:3901-3905.
26. Patton JC, Sherman GG, Coovadia AH, et al. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clinical and Vaccine Immunology. 2006;13:152-155.
27. Zijenah LS, Tobaiwa O, Rusakaniko S, et al. Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnoses of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr. 2005;39:391-394.
28. Naver L, Ehrnst A, Belfrage E, et al. Long-term pattern of HIV-1 RNA load in perinatally infected children. Scand J Infect Dis. 1999;31:337-343.
29. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med. 1997;336:1337-1342.
30. Rouet F, Sakarovitch C, Msellati P, et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics. 2003;112:e289-e297.
31. Schupbach J, Tomasik Z, Jendis J, et al. IgG, IgM, and IgA response to HIV in infants born to HIV-1-infected mothers. Swiss Neonatal HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7:421-427.
32. Knuchel MC, Tomasik Z, Speck RF, et al. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings. J Clin Virol. 2006;36:64-67.
33. Ledergerber B, Flepp M, Boni J, et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis. 2000;181:1280-1288.
34. Young NL, Shaffer N, Chaowanachan T. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr. 2000;24:401-407.
35. Charboneau TT, Wade NA, Weiner L, et al. Vertical transmission of HIV in New York State: a basis for statewide testing of newborns. AIDS Patient Care STDs. 1997;11:227-236.
36. Bremer JW, Lew JF, Cooper E, et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr. 1996;129:198-207.
37. Obaro SK, Losikoff P, Harwell J, et al. Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A/G. Pediatr Infect Dis J. 2005;24:183-184.
38. O'Shea S, Mullen J, Tong CY. Pediatric diagnosis of human immunodeficiency virus type 1 infection: the problem of false negative DNA polymerase chain reaction results. Pediatr Infect Dis J. 2003;22:476-477.
39. Hermione Lyall EG, Taylor GP, Clarke J, et al. Polymerase chain reaction diagnosis of human immunodeficiency virus infection. Pediatr Infect Dis J. 2003;22:295.